BVXP Insider Trading

Insider Ownership Percentage: 8.02%
Insider Buying (Last 12 Months): £11,574.53
Insider Selling (Last 12 Months): £2,604,000

Bioventix Insider Trading History Chart

This chart shows the insider buying and selling history at Bioventix by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
20222023202420250bought0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-200M-100M0100M200MTotal Insider BuyingTotal Insider Selling

Bioventix Share Price & Price History

Current Price: GBX 3,190
Price Change: Price Decrease of -10 (-0.31%)
As of 01/22/2025 01:29 PM ET

This chart shows the closing price history over time for BVXP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MarAprMayJunJulAugSepOctNovDecJan3,190.00Closing price on 01/22/25:

Bioventix Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Bioventix (LON:BVXP)

62.31% of Bioventix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Bioventix logo
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Read More on Bioventix

Today's Range

Now: GBX 3,190
Low: 3,130
High: 3,200

50 Day Range

MA: GBX 3,451.98
Low: 3,101
High: 3,975

52 Week Range

Now: GBX 3,190
Low: 2,977
High: 5,100

Volume

9,795 shs

Average Volume

3,918 shs

Market Capitalization

£166.52 million

P/E Ratio

1,957.06

Dividend Yield

3.95%

Beta

0.35

Who are the company insiders with the largest holdings of Bioventix?

Bioventix's top insider shareholders include:
  1. Bruce Hiscock (Insider)
  2. Ian James Nicholson (Insider)
  3. Peter John Harrison (Insider)
Learn More about top insider investors at Bioventix.